Anticancer compounds based on isatin-derivatives: Strategies to ameliorate selectivity and efficiency

RE Ferraz de Paiva, EG Vieira… - Frontiers in molecular …, 2021 - frontiersin.org
In this review we compare and discuss results of compounds already reported as anticancer
agents based on isatin-derivatives, metalated as well as non-metallated. Isatin compounds …

Copper complexes as anticancer agents targeting topoisomerases I and II

C Molinaro, A Martoriati, L Pelinski, K Cailliau - Cancers, 2020 - mdpi.com
Simple Summary Organometallics, such as copper compounds, are cancer
chemotherapeutics used alone or in combination with other drugs. One small group of …

From coins to cancer therapy: Gold, silver and copper complexes targeting human topoisomerases

J Ceramella, A Mariconda, D Iacopetta… - Bioorganic & Medicinal …, 2020 - Elsevier
Cancer is a complex issue and, even though the prevention basics and therapy have been
implemented, it is still the second leading death cause worldwide. With the hope to discover …

The design and discovery of topoisomerase I inhibitors as anticancer therapies

E Martín-Encinas, A Selas, F Palacios… - Expert Opinion on Drug …, 2022 - Taylor & Francis
Introduction Cancer has been identified as one of the leading causes of death worldwide.
The biological target of some anticancer agents is topoisomerase I, an enzyme involved in …

Strategies targeting DNA topoisomerase I in cancer chemotherapy: camptothecins, nanocarriers for camptothecins, organic non-camptothecin compounds and metal …

K Gokduman - Current drug targets, 2016 - ingentaconnect.com
Topoisomerase I (Topo I) is a nuclear enzyme engaged in adjustment of DNA topological
structure during cell cycle by cleaving and reannealing one of the two strands of the DNA …

Oxidovanadium (IV) complexes with chrysin and silibinin: anticancer activity and mechanisms of action in a human colon adenocarcinoma model

IE Leon, JF Cadavid-Vargas, I Tiscornia… - JBIC Journal of …, 2015 - Springer
Vanadium compounds were studied during recent years to be considered as a
representative of a new class of nonplatinum metal antitumor agents in combination to its …

Copper as the target for anticancer nanomedicine

S Shao, J Si, Y Shen - Advanced Therapeutics, 2019 - Wiley Online Library
Microelements such as copper are essential and involved in various biological processes
and under strict homeostatic regulation. Compared to healthy individuals, cancer patients …

Low-dimensional compounds containing bioactive ligands. Part VI: Synthesis, structures, in vitro DNA binding, antimicrobial and anticancer properties of first row …

I Potočňák, P Vranec, V Farkasová, D Sabolová… - Journal of Inorganic …, 2016 - Elsevier
A series of new 3d metal complexes with 5-chloro-quinolin-8-ol (ClQ),[Mn (ClQ) 2](1),[Fe
(ClQ) 3](2),[Co (ClQ) 2 (H 2 O) 2](3),[Ni (ClQ) 2 (H 2 O) 2](4),[Cu (ClQ) 2](5),[Zn (ClQ) 2 (H 2 …

Non-mutagenic Ru (ii) complexes: cytotoxicity, topoisomerase IB inhibition, DNA and HSA binding

MM Da Silva, MS De Camargo, RS Correa… - Dalton …, 2019 - pubs.rsc.org
Herein we discuss five ruthenium (II) complexes with good cytotoxicity against cancer cells.
These complexes are named [Ru (tzdt)(bipy)(dppb)] PF6 (1),[Ru (mmi)(bipy)(dppb)] PF6 …

NHC-Ag(I) and NHC-Au(I) Complexes with N-Boc-Protected α-Amino Acidate Counterions Powerfully Affect the Growth of MDA-MB-231 Cells

D Iacopetta, C Costabile, M La Chimia… - ACS Medicinal …, 2023 - ACS Publications
N-Heterocyclic carbene (NHC) metal complexes are attracting scientists' interest as an
alluring class of metallodrugs. Indeed, the versatile functionalization of NHC ligands makes …